Skip to content
‹ Back to IndustriesSciences

The Fungus from The Last of Us Could Help Fight Cancer

The Last of Us, HBO’s videogame-inspired zombie TV epic, opened to rave reviews last month. This drama, led by Game of Thrones stars Pedro Pascal and Bella Ramsey, shows a post-apocalyptic world that has been ravaged by the corydceps fungus after the fungus adapts for survival in the human body. Scarily enough, the fungus from…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Leslie Samuel · · Cancer ResearchCordyceps FungusFungiMycology
Share

Key takeaways

01

The Last of Us, HBO’s videogame-inspired zombie TV epic, opened to rave reviews last month.

02

This drama, led by Game of Thrones stars Pedro Pascal and Bella Ramsey, shows a post-apocalyptic world that has been ravaged by the corydceps fungus after the fungus adapts for survival in the human body.

03

Scarily enough, the fungus from…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The Last of Us, HBO’s videogame-inspired zombie TV epic, opened to rave reviews last month. This drama, led by Game of Thrones stars Pedro Pascal and Bella Ramsey, shows a post-apocalyptic world that has been ravaged by the corydceps fungus after the fungus adapts for survival in the human body. Scarily enough, the fungus from The Last of Us is very, very real, and it’s turned many more casual eyes to the world of mycology. Should people give the cordyceps fungus the horror treatment, though?

Cordyceps’ claim to fame isn’t off base; some species of the fungus are known to infect insects and basically, turn them into zombies. Interest in the series has raised questions of whether a cordyceps-fueled pandemic can actually threaten humanity. Experts in the field of mycology say it is highly improbable and would require major genetic changes, which would probably develop over the course of millions of years.

Although the fungus may be terrifying for invertebrates, outside of The Last of Us’s lore, cordyceps is actually quite useful for humans. It is a widely used ingredient in traditional Chinese medicine, and recent research shows it may even have anti-cancerous properties. So as media consumers clamor for cordyceps content, how is the science community approaching research around the zombie fungus? Leslie Samuel, founder of Interactive Biology, a Master’s in Neurobiology holder, and an experienced science educator, breaks down some of the most recent research surrounding the fungus from The Last of Us.

Leslie’s Thoughts:

“In the field of mycology, which is the study of fungi, there’s been a lot of interest in the cordyceps fungus. That’s the same type of fungus that the show, The Last of Us, is based on. We know that certain species of that fungus can infect ants, turning them into zombies, and when they get infected, those ants will climb up a tree and bite into it, basically committing suicide as the fungus takes over their bodies and [causes] them to release more spores so that they can infect more ants. And the cycle continues like in The Last of Us, but with ants.

But there are also studies that show that certain species of the cordyceps fungus have potential anti-cancer effects. They’ve demonstrated that certain extracts from some species of the cordyceps fungus seems to inhibit the growth of liver cancer. And other studies suggest that there are specific substances in some species that inhibit the inflammatory response in certain immune system cells in mice. Now, there’s still a lot more research that needs to be done to confirm that these effects can actually help in therapies in the future. But this entire field of mycology is fascinating, with these fungi having both harmful and potentially life-saving properties.”

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

Leslie Samuel

Leslie Samuel's journey is a testament to determination and passion. Although his dream of becoming a university professor was initially hampered by the lack of a Ph.D., he didn't let that stop him. Instead, he embraced the digital age, becoming a prominent blogger and YouTuber. Through these platforms, Leslie shared his knowledge, effectively teaching what he would have taught in a classroom, reaching hundreds of thousands of eager learners worldwide. His online success opened doors, leading to his dream job as a university professor in a Doctor of Physical Therapy program, despite the absence of a Ph.D. However, Leslie's impact online was undeniable, prompting him to make the bold decision to transition into a full-time blogger and business coach. Today, through Interactive Biology, Leslie Samuel continues to demonstrate that Biology is not only educational but also immensely enjoyable. His journey is a shining example of how determination and innovation can turn dreams into reality.

B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

AI shows up in all five tracks at ISPE's 2026 Annual Meeting

AI shows up in all five tracks at ISPE's 2026 Annual Meeting

ISPE's 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC explaining why AI appears across every track rather than in a standalone one. Deloitte's December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE's 2026 Annual Meeting has no dedicated AI track; program chairs expect AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte's December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own financial outlook but only 41% optimistic about the global economy, the mood the program is built for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation with tagged models enables tracking of tumor growth in the organ where it naturally occurs, supporting clinically relevant assessment of therapies delivered in that setting.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Clinical data harmonization is the bottleneck for life sciences AI

Clinical data harmonization is the bottleneck for life sciences AI

Life sciences companies moving AI from experimentation to scale keep running into messy trial data. One study can draw on EDC, health records, eCOA tools, wearables and imaging, and data teams at pharma SMEs often spend up to 80% of their time wrangling it. Commentators point to lakehouse architectures and data-cleansing AI agents, though the agents are still at proof of concept.

  • 01Treat automation gains as proof-of-concept for now; evaluate AI/harmonization choices based on data readiness, governance, and whether the architecture supports traceability and regulatory needs.

Sep 26, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

Leslie Samuel's journey is a testament to determination and passion. Although his dream of becoming a university professor was initially hampered by the lack of a Ph.D., he didn't let that stop him. Instead, he embraced the digital age, becoming a prominent blogger and YouTuber. Through these platforms, Leslie shared his knowledge, effectively teaching what he would have taught in a classroom, reaching hundreds of thousands of eager learners worldwide. His online success opened doors, leading to his dream job as a university professor in a Doctor of Physical Therapy program, despite the absence of a Ph.D. However, Leslie's impact online was undeniable, prompting him to make the bold decision to transition into a full-time blogger and business coach. Today, through Interactive Biology, Leslie Samuel continues to demonstrate that Biology is not only educational but also immensely enjoyable. His journey is a shining example of how determination and innovation can turn dreams into reality.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512